nephrotic syndrome and a case report
DESCRIPTION
pathophysiology and management of nephrotic syndrome and a case reportTRANSCRIPT
A case presentation and review on
Nephrotic syndrome
By,Surya prakash singhROLL: 28VCOP, MGM
*A male patient aged 6 yrs was admitted in pediatric ward with ipno 1146 on 12/4/14 with complain of hematuria and burning micturition.
A male child patient aged 6 yrs was admitted in pediatric ward with ipno 1146 on 12/4/14.Present complains:
hematuriaburning micturition
History of present illness:Subject developed dyspnea 2 days back
and on the present day morning blood in urine was found
and was admitted 5.30 pm 12/4/14.Past family history:
not significant (NO ONE HAD HEMATURIA)
12th 13th 14th 15th 16th
PATIENT CONDITION C/C C/C C/C C/C C/C
TEMP Afebrile AFebrile Afebrile &Malaise
Afebrile AFebrile
Facial tone Pallor Pallor Pallor normal Normal
BLOOD PRESSURE mmHg
90/50 100/80 114/84 110/80 110/80
PULSE RATE / min 98 90 80 92 98HEART AND LUNGS NAD NAD NAD NAD NADPARA ABDOMEN SOFT SOFT SOFT SOFT SOFT
HEMATURIA PRESENT PRESENT DECREASED
SCANTY ABSENT
1. CUE COMPLETE URINE EXAMINATION:urine proteins: 420 (0-8 mg/dl)creatinine: 39 (30-40 mg/dl) P/C ratio : 10.70 (<0.2)pus cells : 10-15 RBC’s: LOADED 2. Abdomen USG:urinary bladder: walls are irregular and thickenedIMPRESSION: cystitis (chronic)
3. Culture Test: NEGATIVE
4. COMPLETE BLOOD PICTURETEST RESULT NORMALWBC 7600 4 -11 K /CCRBC 4.9 MILL/ 4.5- 5.5 * 10 6
HGB 13.2 g/dl 13-16g/dlHCT 38.6 % 40-60%MCV 78.6 flu 80-100MCH 26.9 26-34MCHC 34.2 g/dl 31-37%PLT 3.14 Lac/cu 10k-4.5kBlood urea 26 mg/dl 7-21 mg/dlBlood creatinine
0.7 mg/dl 0.8mg/dl
LYMPHOCYTESMIXEDNEUTROPHILS
59 %4.4%35.9%
20-40
40-60Serum electrolytes
normal
TESTS WHICH WERE ORDERED BUT BEFORE THEIR ARRIVAL PATEINT ABSCONDED AND RESULT UNKNOWN.
ASO TITERC3 LEVELSX RAY KUB (KIDNEY, URETERS, BLADDER)
*DEFINITION*PATHOPHYSIOLOGY*DIAGNOSIS*DIFFERENTIAL DIAGNOSIS*LAB EVALUATION*AGE DISTRIBUTION*TREATMENT*COMPLICATIONS*PROGNOSIS
*IT’S A CONDITION CHARECTERISED BY PROTEINURIA RESULTING IN OEDEMA WITH GRADUAL HYPERLIPIDEMIA.
1.EDEMA
1.EDEMA
• Decreased oncotic pressure results in increased hepatic production of VLDL
• Urinary loss of heparin sulfate and LCAT results in decreased lipoprotein lipase activity with a decreased metabolism of VLDL
• Urinary loss of HDL and LCAT results in an increased LDL/HDL ratio
2. Hyperlipidemia
3. Hypercoagulability
4. Immunodeficiency
• Hypogammaglobulinemia secondary to urinary losses• Hypocomplementemia secondary to urinary losses• Decreased cellular immunity, potentially secondary to
urinary losses of Zn and Fe
5. MiscellaneousWILL BE DISCUSSED NEXT SLIDE
1. Minimal Change Nephrotic Syndrome (MCNS) 76%.()
2. Focal & Segmental Glomerulosclerosis (FSGS) 9%. (matrix expansion)
3. Membranoproliferative Glomerulonephritis (MPGN) 7%. (matris expansion and roliferation)
4. Membranous Glomerulonephritis (MGN) 2%.( fenestrae damage)
5. Other glomerulopathies 6%(whole bowmans damage)
Hepatitis B and CHIVMalariaFilariasis SLEDiabetes mellitusSever sepsisMetabolic disorder Glycogen storage diseaseHematologic and oncologic disease Leukemia Hodgkin's LymphomaDrugsMercury, Heroin, Lithium NSAIDs
Hypoproteinemia is not related to Proteinuria
Pediatric nephro logy handouts by Dr. chris clardy MD.
HYPOTHYROIDISM
T3, T4 LEVELS
MYELIDOSISPEPTIDE PLAQUES INHEARTRENAL
ULTRASOUND
LIVER CIRHOSIS CHF ENDOCARDITIS LFT’S (CARDIAC BIOMARKERS AND LIPD PROFILES)
1. Edema (gut, Facial, pedal)2. Proteinuria3. Abdominal discomfort due to oedema4. Bacterial peritonitis (pulmonary, cardiac)5. Poor appetite
Bagga, Arvind, et al. "Nephrotic Syndrome in Children." Indian J Med Res 122 (2005): 13-28.Print.
*Urinalysis*RBC HIGHER IN DIPSTIK*PROTEINS >150mg/day*CREATININE >0.8 mg/dl*P/C RATION >0.2
*Total protein (>150 mg /day ) and albumin*Electrolytes, calcium, BUN .*Cholesterol (±triglycerides) >200mg/dl*Blood pressure
*PPD: (purified protein derivative)>5mm ERYTHEMA TUBERCULOSIS IS PRESENT*C3: (75-135 mg/dl)C3,C4 ARE INFLAMMATORY COMPLEMTARY COMPONENTSDECRESES IN CASE OF AUTOIMMUNE DISEASE CONDITION
SLETRANSPLANTATIONHEPATOMEGALYINCREASE IN CASE OF CANCER, ULCERATIVE COLITIS*ASO TITER: ( antistreptolysin O)* THIS TEST IS POSITIVE WHEN STREPTOCOCCAL INFECTION IS
PRESENT *ANA: (anti nuclear antibodies) SPECIAL PROTEINS WHICH ARE PRODUCED WHEN AUTOIMMUNE SYSTEM GETS ATIVATED.
1. EDEMA*FUROSEMIDE = 1mg/KG/DAY*SPIRANOLCATONE= 2mg/KG/DAY
2. CORTICOSTEROIDS*PREDNISOLONE= 2mg/KG/DAY – 3 days (80mg/D)
1.5mg/KG/DAY- 8 daysIF PREDNISOLONE FAILS CYCLOPHOSPHAMIDE= 2mg/KG/DAY – 21days
3. IMMUNOSUPRESSANTS( Anti – ANA )*Cyclosporine = 5- 15 mg/kg/day ORAL BD*Tacrolimus = 0.5 , 1 , 5 mg tab, BD
1.HTN= ACE/ARB2.ANTIHYYPERLIPIDEMICS= NICOTINIC ACID/FIBRATES/
STATINS3.PNEUMOCOCCAL VACCINE4.COLLOIODAL INFUSION= PROTEIN1gm/kg
ACCOMPAINED WITH LASIX 1MG/KG
COMPLICATIONS OF NEPHROTIC SYNDROME
Infectious PeritonitisCellulitisDisseminated Varicella Infection
Cardiovascular HypertensionHyperlipidemiaCoronary artery disease
Respiratory Pleural effusionPulmonary embolism
Hematologic Venous (more common) or arterial (less common) THROMBOSISAnemia
Gastrointestinal Intussusception (merging oF intestinal parts)
Renal Acute renal failureRenal vein thrombosis
Endocrinologic Reduced bone mineral densityHypothyroidism, clinical and subclinical (more common in CNS)
Neurologic Cerebral venous thrombosis
Treatement-related General Infection, hypertension
Steroids Growth impairment, reduced bone density, posterior capsular cataracts, avascular necrosis of femoral head
Alkylating agents Hemorrhagic cystitis, dose-related oligospermia and premature ovarian failure, increased risk of malignancy
Calcineurin inhibitors
Gingival hyperplasia, hirsutism, hyperkalemia, encephalopathy
Mycophenolate mofetil (MMF)
Nausea, vomiting, diarrhea, constipation, dose-related leukopenia, headache
Prognosis
Minimal Change Disease
Often Relapse (Over 90%)
Resolves with no permanent kidney damage
FOCAL SEGMENTAL NS
Usually results in CKD (>50%) in5-10 years)
MEMBRANO PROLIFERATIVE
NS
50% CKDwithin 10-15 years
DEF: LIKELYHOOD
OF THE OUTCOME
Initial assessment based on the subjective findings was made as
Burning micturition and hematuria for evaluation
After analyzing both subjective and objective findings it was diagnosed as
NEPHRITIC PHASE OF NEPHROTIC SYNDROME
15-4-14= NO PEDAL EDEMA BUT FACIAL PUFFYNESS PRESENT
ROA GENERIC NAME
CATEGORY DOSE FREQ 12th 13th- 16TH
IV CEFOTOXIME ANTI-BIOTIC 500 mg TID
TAB PARACETAMOL
ANTI-PYRETIC 80mg QID
IV ISO-P Oral fluids 300 ML OD
TAB DICYCLOMINE ANTI-SPASMODIC
oral ORS Oral fluids OVER THE DAY
QID
* diet counselling : *Stop HDL containing foods like (poori, bonda)*Idli and 4 eggs per day was advised (HPD)*High fluid intake than normal (for input output assessment)*Salt totally restricted (as fluid retention may happen)
*Disease counselling*The patient was advised to stay in hospital after fading of
symptoms because ASO TITER AND C3 TESTS WERE ORDERED AND WERE EXPECTED AFTER FOUR DAYS, BUT Despite of doctors advice THE PATIENT ABSCONDED
*Lau, Keith, et al. "Steroid Responsive Nephrotic Syndrome in IgA Nephropathy with FSGS." The
* Internet Journal of Nephrology 4 (2008): n. pag. Print.* "Pediatric Nephrotic Syndrome." Pediatric Nephrotic Syndrome.
N.p., n.d. Web. <http://*emedicine.medscape.com>.*USA. NIH. NIDDK. Childhood Nephrotic Syndrome. N.p.: n.p., 2008.
Print.*Trachtman, Howard. “Common Diseases: Minimal Change Nephrotic
Syndrome.” Nephrology*Self Assessment Program 11 (2012) 19-20. Print.*Trachtman, Howard. “Common Diseases: Focal Segmental
Glomerulosclerosis.” Nephrology*Self Assessment Program 11 (2012) 20-. Print.*Cho, MH. “”Pathophysiology of Minimal Change Nephrotic
Syndrome and Focal Segmental*Glomerulosclerosis.” Pubmed (2007).
*HARRISONS INTERNAL MEDICINE*GYTON AND HALL PHYSIOLOGY*DIAGNOSIS AND TREATMENT BY LWARENCE AND
MYER*JOSEPH T. DIPIRO